Pfizer

Pfizer bivalent COVID-19 vaccine to be available in Saskatchewan for ages 12 and up thumbnail
General
Pfizer bivalent COVID-19 vaccine to be available in Saskatchewan for ages 12 and up

The province says it will be available at health authority-booked and walk-in clinics, as well as clinics in Indigenous communities. Author of the article: This photo shows a vial of the Moderna Covid-19 vaccine, Bivalent, at AltaMed Medical clinic in Los Angeles, California, on October 6, 2022. (Photo by RINGO CHIU / AFP) Photo by…

Pfizer CEO tests positive for COVID for a second time thumbnail
General
Pfizer CEO tests positive for COVID for a second time

Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. “I’m feeling well and symptom free,” Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid. Paxlovid is an antiviral medication that is…

Pfizer Plans a Vaccine to Target All Coronaviruses thumbnail
Health & Medical
Pfizer Plans a Vaccine to Target All Coronaviruses

June 30, 2022 – Ask the sibling of any celebrity and they’ll tell you they don’t get anywhere near the same attention. The same is true for coronaviruses – the one that causes COVID-19 has been in the spotlight for more than 2 years now, while the others at the moment circulate in relative obscurity.With…

Pfizer Recalls Another Blood Pressure Medication thumbnail
Health & Medical
Pfizer Recalls Another Blood Pressure Medication

April 25, 2022The pharmaceutical company Pfizer has voluntary recalled a blood pressure medication for the second time in a month.Pfizer is recalling five lots of blood pressure medicine Accupril because of elevated levels of a nitrosamine, Nnitroso-quinapril, the company said in a news release posted Friday on the FDA website.Nitrosamines are found in water and…

Fourth Pfizer Dose Better for Severe Than Symptomatic COVID: Study thumbnail
Health & Medical
Fourth Pfizer Dose Better for Severe Than Symptomatic COVID: Study

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A fourth dose of the Pfizer-BioNTech vaccine is effective in reducing the short-term risk for COVID-19 infection, hospitalization, and death in people who got a third dose at least 4 months before, a large study published Wednesday shows. However, Paul Offit,…

Pfizer Recalls BP Drugs Because of Potential Carcinogen thumbnail
Health & Medical
Pfizer Recalls BP Drugs Because of Potential Carcinogen

Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the company announced.  The affected products are quinapril HCI/hydrochlorothiazide (Accuretic) tablets that Pfizer distributes, and two authorized generics, quinapril plus hydrochlorothiazide and quinapril HCI/hydrochlorothiazide, distributed by Greenstone. The drugs have been withdrawn because of the presence of nitrosamine, N-nitroso-quinapril. “Although long-term ingestion of N-nitroso-quinapril…

CARPHA: Pfizer 5-11 formula not yet given EUL thumbnail
General
CARPHA: Pfizer 5-11 formula not yet given EUL

News Paula Lindo 2 Hrs AgoA nurse prepares a shot of the Pfizer vaccine. AP Photo.The Caribbean Public Health Agency (CARPHA) said the paediatric formulation of the Pfizer covid19 vaccine has not yet been granted emergency use listing by the World Health Organization (WHO). It said its Caribbean Regulatory System (CARPHA-CRS) had not yet recommended…

How Pfizer made an effective anti-covid pill thumbnail
Technology
How Pfizer made an effective anti-covid pill

In the early days of the pandemic, all eyes were on potential vaccines. In May 2020, the US announced Operation Warp Speed, a plan to spend billions on vaccine development. But mostly out of sight of the news media, quieter efforts to custom-design a covid-19 pill were moving forward with similar urgency and hope. Chemists…

Pfizer: Final Data Shows COVID Pill Stays Strong Against Severe Illness thumbnail
Health & Medical
Pfizer: Final Data Shows COVID Pill Stays Strong Against Severe Illness

By Robin Foster HealthDay Reporter TUESDAY, Dec. 14, 2021 (HealthDay News) — Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people at high risk for severe illness.The latest results, which reinforce an earlier analysis released in November, Pfizer’s drug cut hospitalizations and deaths…

Pfizer to apply for FDA approval for first COVID vaccine booster shot for kids aged 16 and 17 thumbnail
General
Pfizer to apply for FDA approval for first COVID vaccine booster shot for kids aged 16 and 17

Pfizer is seeking FDA approval for COVID-19 booster shots for older teens as the omicron variant of the virus continues to spread worldwide.The drug-maker is expected to apply for regulatory approval for the booster shot of their vaccine this week.If approved, children aged 16 and 17 would be able to receive the jab. It would…